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Introduction 
Polybrominated diphenyl ethers (PBDEs) are considered to be a cost effective and efficient way to reduce 
flammability therefore reducing harm caused by fires.  PBDEs are incorporated into a variety of 
manufactured products and are found worldwide in biological and environmental samples (e.g. Hites et al. 
2004).   
   
Unlike other persistent organic pollutants there is limited data on PBDE concentrations by age and/or 
other population specific factors.  Some studies have shown no variation in adult serum PBDE 
concentrations with age (e.g. Mazdai et al., 2003, Meironyte Guvenius et al., 2003) while Petreas et al. 
(2003) and Schecter et al. (2005) found results to be suggestive of an age trend in adult data but no 
statistically significant correlation was found.  In addition to the data on adult concentrations there is 
limited data which investigates the levels of PBDEs in infants and young children.  Fangström et al. 
(2005) showed that in seven year olds there was no difference in PBDE concentration when compared to 
adult concentrations.  While Thomsen et al. (2002, 2005) found the concentration of PBDEs in pooled 
samples of blood serum from a 0-4 years age group to be higher than other age groups (4 to > 60 years).  
In addition, a family of four was studied in the U.S. and the concentrations were found to be greatest in the 
18-month-old infant followed by the 5 year old child, then the mother and father (Fischer et al., 2006).   
 
The objectives of this study were to assess age, gender and regional trends of PBDE concentrations in a 
representative sample of the Australian population.  
 
Materials and Methods 
Human blood sera was collected and pooled for analysis as a continuation of a preliminary investigation 
of PBDE concentrations in the Australian population (Harden et al. 2004).  In the current study, pools of 
sera collected in 2002/03 along with pools collected in 2004/05 were used.  De-identified serum samples 
were obtained from Sullivan and Nicolaides Pathology from surplus stored sera that had been collected as 
part of routine pathology testing.   
 
Prior to pooling, all samples were stratified according to age, gender and geographical region.  The age 
groups were: 0-4 years (2004/05 samples only); less than 16 years (2002/03 samples only); 5-15 years 
(2004/05 samples only); 16 to 30 years (2002/03 and 2004/05); 31 to 45 years (2002/03 and 2004/05); 46 
to 60 years (2002/03 and 2004/05); and greater than 60 years (2002/03 and 2004/05).  Sera were collected 
from both males and females.  For the 2002/03 samples the five regions were: Northeast Urban, including 
Brisbane, Tweed, Gold Coast and major population centres in Queensland; Southeast Urban including 
Sydney, Canberra, Wollongong, Newcastle and other major population centres in New South Wales; 
South Urban including Melbourne, Adelaide, Hobart and other major population centres in Victoria and 
South Australia; West including Perth and other major population areas in Western Australia; and Rural 
including rural areas from all States and the Northern Territory (for map see Figure 1, Harden et al. 2004).  
The 2005 samples were taken from the Northeast Urban region only.   
 
Up to 200 samples were collected per stratum which was then divided randomly into two pools, with a 
maximum of 100 samples in each pool.  For this study, 8132 individual samples were used in 85 pools.  
For adult samples 1 ml of each sample was pooled while for samples in the 0-4, 5-15 and <16 years old 
groups, the volume may have been less than 1 ml, therefore, the entire sample volume (1 ml or less) was 
pooled.     
 
The samples were sent to ERGO/Eurofins, Hamburg, Germany where the following congeners were 
targeted for analysis: BDE- 1, -2, -3, -7, -10, -13, -15, -17, -25, -28, -35, -47, -49, -66, -71, -75, -77, -85, -
99, -100, -116, -119, -126, -138, -140, -153, -154, -155, -156, -181, -183, -197, -203, -207 and -209.  The 
measurement was done by means of isotope dilution technique using HRGC/HRMS (high resolution gas 
chromatography/high resolution mass spectrometry) (see Toms et al. 2006 for details).  The study 
provided two phases of quality control/ quality assurance including sampling replication and inter-
laboratory calibration with 10 duplicate pools sent to Health Canada, Ottawa, Canada.  There was good 
reproducibility between the replicate pools of a given stratum.  The inter-laboratory calibration showed no 
systematic differences between the two laboratories, however two samples showed an elevation of lower 
brominated BDEs that indicated post-sampling contamination.  These 2 datasets were subsequently 
removed and the remaining set examined for similar contamination. Ethics approval for this study was 
granted on 20 September 2002 by The University of Queensland Medical Research Ethics Committee. 
 
Results and discussion 
Overall, PBDEs were detected in all 85 pools of human blood serum ranging from 6.4 to 80 ng.g-1 lipid.  
A trend by age was observed with elevated PBDE concentrations in the 0-4 and < 16 (5-15) years age 
groups compared to the >16 years age groups (Table 1).  The PBDE concentrations in the youngest groups 
were around a factor two higher than observed in the 5-15 years - 2004/05 samples and around a factor 
four higher than in the > 16 years age groups combined - 2004/05 samples.  In comparison to this steep 
decrease from the very young children to the older children, subsequent decreases with age are apparent 
but much smaller (Figure 1).  There is no clear decrease in the concentration between the two oldest 
groups.  No relationship was found between PBDE concentrations and gender or region.   
 
Table 1. Mean ΣPBDE concentrations (ng.g-1 lipid) by age group and year of collection. 
 Mean ± standard deviation (median) 
Age 2002/03 (All regions) 2004/05 (Northeast) 
> 16 years 15 ± 5 (13) 18 ± 5 (16) 
< 16 years (excl. 0-4) 28 ± 8 (29) 29 ± 7 (29) 
0-4 years n/a 73 ± 7 (75) 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 ΣPBDE concentration (ng.g-1 lipid) in each pool by the respective mean age (years) of 
donors in each pool 
 
The congener profile of PBDEs in both the 2002/03 and 2004/05 samples was dominated by BDE-47 
(Table 2).  No differences in congener profile by age, gender or region were observed.  
 
Table 2. Mean and range contribution (%) of congeners to the ΣPBDE concentration by year. 
 2002/03 2004/05 
congeners Mean (%) Range (%) Mean (%) Range (%) 
47 32 18-47 24 14-37 
153 14 7-23 12 7-25 
99 13 n.d.-24 8 4-13 
100 8 5-16 7 4-13 
209 6 n.d.-29 4 n.d.-29 
154 2 1-3 1 1-2 
n.d. – non-detect 
 
The study provides important information on the concentration of PBDEs in a large number of samples 
across the lifespan from 0-4 years up to greater than 60 years.  Unfortunately it cannot be assumed that the 
study results represent the peak concentration of PBDEs in the Australian population.  This is due to the 
use of pooled samples which means that the reported concentration of PBDEs and the mean age of the 
pool is an average of the individual donors’ PBDE concentrations and ages, respectively.  Identifying the 
likely peak age by the use of individual samples or smaller age brackets at which the concentration is the 
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highest may make it possible to evaluate routes of exposure at this peak age.  This information could then 
be used to assess factors leading to these elevated concentrations in this age group taking into 
consideration metabolism and other age specific factors.  Additional research including sample collection 
and analysis is underway to further investigate PBDEs and age.    
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